AMY STEWART: Open Payments
NPI 1568992766 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220,769 in 503 payments from 25 companies in 2025. Trend: 2023 $70,555 · 2024 $176,813 · 2025 $220,769
Speaker / faculty: $122,894Consulting: $46,924Travel & lodging: $39,301Food & beverage: $11,649
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 143 | $102,395 |
| Lilly USA, LLC | 81 | $39,410 |
| PFIZER INC. | 50 | $24,420 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $22,924 |
| Phathom Pharmaceuticals, Inc. | 33 | $12,072 |
| Exact Sciences Corporation | 12 | $5,573 |
| Eli Lilly and Company | 4 | $2,877 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $2,381 |
| ABBVIE INC. | 28 | $1,521 |
| Celltrion USA Inc. | 9 | $1,506 |
Products named: TREMFYA, OMVOH, VELSIPITY, ENTYVIO, VOQUEZNA, DUPIXENT, Cologuard Collection Kit, STELARA.
Industry payments across DC — which companies pay providers there.
